NASDAQ: SIBN · Industrial Applications and Services · 13 alerts · CIK 1459839
Share price
$23.41Close, Nov 16
Market cap
$1.06B
Shares outstanding
45.11MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All SI-BONE, Inc. filings on SEC EDGAR ↗
Laura Francis, CEO, sold 75,000 shares of SI-BONE, Inc. at $25.30 a share, worth $1.9M in total on Nov 4, 2026. Shares held after the trade: 304,256 (-19.8%).
SI-BONE SVP, Ops & Adm/Chief Legal Ofr Michael A. Pisetsky Sells $899K of Stock
Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Ofr, sold 36,241 shares of SI-BONE, Inc. at $24.80 a share, worth $899K in total on Nov 4, 2026. Shares held after the trade: 40,167 (-47.4%).
SI-BONE Chief Op & Financial Officer Anshul Maheshwari Sells $81.2K of Stock
Anshul Maheshwari, Chief Op & Financial Officer, sold 3,247 shares of SI-BONE, Inc. at $25.00 a share, worth $81.2K in total on Nov 4, 2026. Shares held after the trade: 211,250 (-1.5%).
SI-BONE Director Jeffrey W. Dunn Sells $418K of Stock
Jeffrey W. Dunn, Director, sold 20,000 shares of SI-BONE, Inc. at $20.89 a share, worth $418K in total on Nov 2, 2026. Shares held after the trade: 16,057 (-55.5%).
SI-BONE, Inc. reported revenue of $55.7 million for the third quarter of 2026, representing a 14.5% increase over the same period in 2025. The company reduced its quarterly net loss to $3.6 million compared to $4.6 million in the prior year, driven by improved gross margins and controlled operating expense growth.
SI-BONE SVP, Ops & Adm/Chief Legal Ofr Michael A. Pisetsky Sells $656K of Stock
Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Ofr, sold 29,665 shares of SI-BONE, Inc. at $22.11 a share, worth $656K in total on Oct 29, 2026. Shares held after the trade: 164,444 (-15.3%).
SI-BONE Chief Op & Financial Officer Anshul Maheshwari Sells $84.1K of Stock
Anshul Maheshwari, Chief Op & Financial Officer, sold 3,738 shares of SI-BONE, Inc. at $22.50 a share, worth $84.1K in total on Oct 29, 2026. Shares held after the trade: 214,497 (-1.7%).
SI-BONE delivered a strong Q2 2026 with 15% revenue growth and significant adjusted EBITDA improvement, driven by broad-based procedure volume and favorable CMS reimbursement updates for its Granite and SI joint portfolios.
SI-BONE reported third quarter 2026 worldwide revenue of $55.7 million, a 14.5% increase year-over-year, driven by 20% growth in U.S. procedure volumes. The company improved its net loss to $3.6 million and achieved positive adjusted EBITDA of $3.0 million while reaffirming its full-year 2026 revenue guidance.
Term
Q3 2026
“Robust third-quarter growth in procedure volumes and active physicians underscores rising demand for our diversified and differentiated platform technologies. We enter the fourth quarter with a record number of active physicians, favorable DRG changes and exceptional early uptake in our alpha launch of iFuse Granite Onyx, our new platform technology that expands our estimated total addressable market to approximately $5 billion. These drivers position us for an excellent finish to 2026 and enter 2027 with the strongest foundation for growth acceleration in our company's history.”